Mar 07, 2017 12:20 pm UTC| Business
Dublin, March 07, 2017 -- Research and Markets has announced the addition of the "Global Robotics Market, Volume Forecast" report to their offering. The global demand of robots...
Mar 07, 2017 12:19 pm UTC| Business
Dublin, March 07, 2017 -- Research and Markets has announced the addition of the "Latin America Advanced Farming Technique Market 2016-2022" report to their offering. The Latin...
Mar 07, 2017 12:15 pm UTC| Business
GREENWICH, CT, March 07, 2017 -- Fifth Street Asset Management Inc. (NASDAQ:FSAM) (“FSAM”) announced today that it plans to report earnings for the fourth quarter and fiscal year ended December 31, 2016 before the...
Perion Reports Fourth Quarter and Full Year 2016 Results
Mar 07, 2017 12:09 pm UTC| Business
Fourth Quarter Revenues $84.5 Million And Annual Revenues $312.8 Million TEL AVIV NEW YORK, March 07, 2017 -- Perion Network Ltd. (NASDAQ:PERI), a global technology leader in high-quality advertising solutions for...
Mar 07, 2017 12:05 pm UTC| Business
LEXINGTON, Mass., March 07, 2017 -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers,...
Mar 07, 2017 12:03 pm UTC| Business
Dublin, March 07, 2017 -- Research and Markets has announced the addition of the "Advanced Remote Patient Monitoring Systems, 9th Edition (Telemedicine and Hospital Systems, Glucose, Blood Pressure,...
ObsEva Starts Phase 3 Clinical Program for Nolasiban in ART
Mar 07, 2017 12:01 pm UTC| Business
- IMPLANT2 study to confirm efficacy and safety of novel, oral oxytocin receptor antagonist in infertile patients undergoing embryo transfer as part of assisted reproductive technology (ART) - Geneva, Switzerland - 07...